Serge Saxonov - Jul 6, 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol
TXG
Transactions as of
Jul 6, 2021
Transactions value $
-$2,757,477
Form type
4
Date filed
7/8/2021, 04:24 PM
Previous filing
Jun 10, 2021
Next filing
Aug 4, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Options Exercise $26.2K +5.21K +0.58% $5.04* 909K Jul 6, 2021 Direct F1
transaction TXG Class A Common Stock Options Exercise $112K +9.79K +1.08% $11.48 919K Jul 6, 2021 Direct F1
transaction TXG Class A Common Stock Sale -$171K -900 -0.1% $190.12 918K Jul 6, 2021 Direct F1, F2
transaction TXG Class A Common Stock Sale -$325K -1.7K -0.19% $191.07 916K Jul 6, 2021 Direct F1, F3
transaction TXG Class A Common Stock Sale -$772K -4.02K -0.44% $192.20 912K Jul 6, 2021 Direct F1, F4
transaction TXG Class A Common Stock Sale -$585K -3.03K -0.33% $193.27 909K Jul 6, 2021 Direct F1, F5
transaction TXG Class A Common Stock Sale -$535K -2.76K -0.3% $194.13 907K Jul 6, 2021 Direct F1, F6
transaction TXG Class A Common Stock Sale -$390K -2K -0.22% $195.12 905K Jul 6, 2021 Direct F1, F7
transaction TXG Class A Common Stock Sale -$98.2K -500 -0.06% $196.33 904K Jul 6, 2021 Direct F1, F8
transaction TXG Class A Common Stock Sale -$19.7K -100 -0.01% $196.97 904K Jul 6, 2021 Direct F1, F9
holding TXG Class A Common Stock 90K Jul 6, 2021 See Footnote F10

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXG Stock Option (right to buy) Options Exercise $0 -5.21K -6.16% $0.00 79.4K Jul 6, 2021 Class A Common Stock 5.21K $5.04 Direct F1, F11
transaction TXG Stock Option (right to buy) Options Exercise $0 -9.79K -11.19% $0.00 77.7K Jul 6, 2021 Class A Common Stock 9.79K $11.48 Direct F1, F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person.
F2 This transaction was executed in multiple trades at prices ranging from $189.54 to $190.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $190.65 to $191.54. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $191.66 to $192.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5 This transaction was executed in multiple trades at prices ranging from $192.67 to $193.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F6 This transaction was executed in multiple trades at prices ranging from $193.67 to $194.66. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F7 This transaction was executed in multiple trades at prices ranging from $194.68 to $195.65. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F8 This transaction was executed in multiple trades at prices ranging from $195.92 to $196.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F9 This transaction was executed in multiple trades at prices ranging from $196.94 to $196.98. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F10 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F11 This option, originally for 250,000 shares, of which 170,635 have been exercised, vested as to one forty-eighth of the shares on October 1, 2018, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F12 This option, originally for 145,786 shares, of which 68,073 have been exercised, vested as to one forty-eighth of the shares on May 1, 2019, and one-forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.